These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3274511)

  • 1. Quadruple immunosuppressive therapy in whole pancreas transplantation.
    Sollinger HW; Kalayoglu M; Hoffman RM; Deierhoi MH; Belzer FO
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2297-9. PubMed ID: 3274511
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine therapy in pancreas transplantation.
    Davidson I; Lu C; Melone D; Risser R
    Transplant Proc; 1996 Aug; 28(4):2134-5. PubMed ID: 8769179
    [No Abstract]   [Full Text] [Related]  

  • 3. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
    Cole E; Robinson C; Bear R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of immunosuppression on pancreatic graft survival and function.
    La Rocca E; Dubernard JM; Camozzi L; LeFrancois N; Faure JL; Sanseverino R; Melandri M; Finaz J; Martin X; Gelet A
    Transplant Proc; 1987 Oct; 19(5):3950-2. PubMed ID: 3313972
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
    Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation.
    Bruce DS; Newell KA; Woodle ES; Millis JM; Piper JB; Huss E; Thistlethwaite JR
    Transplant Proc; 1996 Aug; 28(4):2136-7. PubMed ID: 8769180
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of three immunosuppressive protocols in patients aged over 50 years.
    Fryd DS; So SK; Kruse L; Canafax DM; Sutherland DE; Simmons RL; Najarian JS
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1530-1. PubMed ID: 3274374
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppressive requirements for small bowel/liver transplantation.
    McAlister V; Grant D; Wall W; Roy A; Ghent C; Zhong R; Duff J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1204-5. PubMed ID: 8442086
    [No Abstract]   [Full Text] [Related]  

  • 9. Quadruple therapy for cadaver renal transplantation.
    Deierhoi MH; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1917-9. PubMed ID: 3274452
    [No Abstract]   [Full Text] [Related]  

  • 10. Quadruple-drug induction therapy in combined renal and pancreatic transplantation--OKT3 versus ATG.
    Illner WD; Theodorakis J; Abendroth D; Schleibner S; Stangl M; Landgraf R; Land W
    Transplant Proc; 1990 Aug; 22(4):1586-7. PubMed ID: 2117795
    [No Abstract]   [Full Text] [Related]  

  • 11. Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
    Canafax DM; Savik SK; Draxler CA; Le CT; Ascher NL; Payne WD; Sutherland DE; Migliori RJ; Simmons RL; Najarian JS
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1947-8. PubMed ID: 3274455
    [No Abstract]   [Full Text] [Related]  

  • 12. Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality.
    Light JA; Aquino A; Ali A; Rodriguez R; Ali S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1927-30. PubMed ID: 3547897
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined kidney-pancreas and parathyroid transplantation: a case report.
    Rahusen F; Munda R; Hariharan S; First MR; Demmy A
    Clin Transplant; 1997 Aug; 11(4):341-3. PubMed ID: 9267727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and impact of acute rejection episodes on short- and long-term graft survival in recipients of simultaneous pancreas-kidney transplantation.
    Cantarovich D; Giral M; Josien R; Karam G; Hourmant M; Dantal J; Blancho G; Soulillou JP
    Transplant Proc; 1995 Feb; 27(1):1319. PubMed ID: 7878897
    [No Abstract]   [Full Text] [Related]  

  • 15. FK 506-based immunosuppression in clinical pancreas transplantation.
    Swanson C; Rubin M; Colquhoun S; Basadonna G; Asshinnik A; Perez R
    Transplant Proc; 1995 Dec; 27(6):3031. PubMed ID: 8539827
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful canine pancreaticoduodenal allotransplantation with cyclosporine and gabexate mesilate.
    Morimoto T; Sakamoto J; Chikashige T; Nishimura M; Yasui K; Yasue M; Miyaishi S; Uchida K; Kano T; Takagi H
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1318-20. PubMed ID: 3152627
    [No Abstract]   [Full Text] [Related]  

  • 17. Stopping prednisone in kidney transplant recipients taking cyclosporine: safety conditions.
    Lloveras J; Masramon J; Orfila A; Cuevas X; Aubia J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2027-8. PubMed ID: 2978888
    [No Abstract]   [Full Text] [Related]  

  • 18. Is induction therapy necessary for successful simultaneous pancreas and kidney transplantation in the cyclosporine era?
    Brayman KL; Egidi MF; Naji A; Friedman AL; Holland MT; Tomaszewski JE; Samini F; Perloff J; Grossman R; Barker CF
    Transplant Proc; 1994 Oct; 26(5):2525-7. PubMed ID: 7940776
    [No Abstract]   [Full Text] [Related]  

  • 19. Quadruple immunosuppressive therapy for liver transplantation.
    Kalayoglu M; Stratta RJ; Hoffmann RM; Sollinger HW; Belzer FO
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):524-9. PubMed ID: 3279646
    [No Abstract]   [Full Text] [Related]  

  • 20. Potent immunosuppression overcomes retransplantation, presensitization, and historical positive crossmatch as transplant risk factors.
    Gaber AO; Thistlethwaite JR; Haag BW; Stuart J; Mayes J; Fellner S; Stuart FP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1915-6. PubMed ID: 3274451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.